FDA Amends Animal Drug Regulations Due to Sponsor Change

Summary

The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect a change in sponsor for two new animal drug applications (NADAs) from Janssen Pharmaceutica NV to Elanco Animal Health, a division of Eli Lilly & Co. Additionally, the FDA is updating the regulations to reflect a change in the sponsor's address for Veterinary Service, Inc.